Atea Pharmaceuticals(AVIR) - 2022 Q1 - Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Jean-Pierre Sommadossi - Founder & CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO & EVP, Legal John Vavricka - Chief Commercial Officer Jonae Barnes - SVP, IR & Corporate Communications Conference Call Participants Hannah Colgan - JPMorgan Umer Raffat - Evercore Nik Gasic - SVB Securities Jonathan Miller - Evercore Operator Good morning, and welcome to the Atea Pharmace ...